An overview of immune checkpoints molecules and related signalling pathways\n\nWith the application of ICBs, scientists have gradually realized that the immune activation generated by targeting CTLA-4 or PD-1 is not sufficient to  https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login https://rextester.com//login